Urinary Catheter Coating Modifications: The Race against Catheter-Associated Infections
Source abstract
Abstract
Urinary catheters are common medical devices, whose main function is to drain the bladder. Although they improve patients’ quality of life, catheter placement predisposes the patient to develop a catheter-associated urinary tract infection (CAUTI). The catheter is used by pathogens as a platform for colonization and biofilm formation, leading to bacteriuria and increasing the risk of developing secondary bloodstream infections. In an effort to prevent microbial colonization, several catheter modifications have been made ranging from introduction of antimicrobial compounds to antifouling coatings. In this review, we discuss the effectiveness of different coatings in preventing catheter colonization in vitro and in vivo, the challenges in fighting CAUTIs, and novel approaches targeting host–catheter–microbe interactions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Urinary Tract Infections Management · Enterobacteriaceae and Cronobacter Research · Bladder and Urothelial Cancer Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
Funding
Science of Wellness Catalyst Seed Grant
References (100+)
Show source-provided references
1. Inappropriate use of urinary catheters and its common complications in different hospital wards
2. Are physicians aware of which of their patients have indwelling urinary catheters?10.1016/S0002-9343(00)00531-3 ↗
3. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization10.1086/510872 ↗
4. Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens10.1093/jac/dkn006 ↗
5. Urinary catheters: History, current status, adverse events and research agenda10.3109/03091902.2015.1085600 ↗
6. Short-duration treatment for catheter-associated urinary tract infections in critically ill trauma patients10.1097/TA.0000000000000822 ↗
7. Niel-Weise, B.S., and van den Broek, P.J. (2012). Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst. Rev., CD004201.10.1002/14651858.CD004201.pub3 ↗
8. Urinary catheterization in medical wards10.4103/0974-777X.62870 ↗
9. Catheter-associated infections: Pathogenesis affects prevention10.1001/archinte.164.8.842 ↗
10. A decade of prevalence surveys in a tertiary-care center: Trends in nosocomial infection rates, device utilization, and patient acuity10.1086/501675 ↗
11. Regional Variation in Urinary Catheter Use and Catheter-Associated Urinary Tract Infection: Results from a National Collaborative10.1086/677825 ↗
12. Guideline for prevention of catheter-associated urinary tract infections 200910.1086/651091 ↗
13. The Ann Arbor Criteria for Appropriate Urinary Catheter Use in Hospitalized Medical Patients: Results Obtained by Using the RAND/UCLA Appropriateness Method10.7326/M14-1304 ↗
14. Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service10.1086/501837 ↗
15. A review of the recent advances in antimicrobial coatings for urinary catheters10.1016/j.actbio.2016.11.070 ↗
16. Schumm, K., and Lam, T.B. (2008). Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst. Rev., CD004013.10.1002/14651858.CD004013.pub3 ↗
17. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update10.1086/675718 ↗
18. Biofilms and catheter-associated urinary tract infections10.1016/S0891-5520(03)00011-4 ↗
19. Nurse-driven protocols and the prevention of catheter-associated urinary tract infections: A systematic review10.1016/j.ajic.2017.07.020 ↗
20. Shear-dependent ’stick-and-roll’ adhesion of type 1 fimbriated Escherichia coli10.1111/j.1365-2958.2004.04226.x ↗
21. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America10.1086/650482 ↗
22. An update on prevention and treatment of catheter-associated urinary tract infections10.1097/QCO.0000000000000031 ↗
23. CDC publishes report on antibiotic resistance threats in the United States for the first time
24. Catheter-associated urinary tract infections: New aspects of novel urinary catheters10.1016/j.ijantimicag.2006.08.020 ↗
25. Activity of a Nitrofurazone Matrix Urinary Catheter against Catheter-Associated Uropathogens10.1128/AAC.37.9.2033 ↗
26. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: Multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial)10.3310/hta16470 ↗
27. Lam, T.B., Omar, M.I., Fisher, E., Gillies, K., and MacLennan, S. (2014). Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst. Rev., CD004013.10.1002/14651858.CD004013.pub4 ↗
28. Antimicrobial strategies for urinary catheters10.1002/jbm.a.36561 ↗
29. Cytotoxicity of latex urinary catheters10.1111/j.1464-410X.1985.tb08992.x ↗
30. Kink, flow and retention properties of urinary catheters part 1: Conventional foley catheters10.1007/s10856-006-6818-0 ↗
31. Hydrophilic-coated catheters for intermittent catheterisation reduce urethral micro trauma: A prospective, randomised, participant-blinded, crossover study of three different types of catheters10.1016/j.eururo.2005.07.009 ↗
32. Antifouling and antimicrobial biomaterials: An overview10.1111/apm.12675 ↗
33. Development of a catheter functionalized by a polydopamine peptide coating with antimicrobial and antibiofilm properties10.1016/j.actbio.2014.12.015 ↗
34. In-vitro antibacterial and anti-encrustation performance of silver-polytetrafluoroethylene nanocomposite coated urinary catheters10.1016/j.jhin.2019.02.012 ↗
35. Formation of encrustations on indwelling urinary catheters in the elderly: A comparison of different types of catheter materials in “blockers” and “nonblockers”10.1016/S0022-5347(17)43412-4 ↗
36. Adherence of bacteria to various urethral catheters and occurrence of catheter-induced urethritis
37. Cost effectiveness of antimicrobial catheters for adults requiring short-term catheterisation in hospital10.1016/j.eururo.2014.05.035 ↗
38. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: A multicentre randomised controlled trial10.1016/S0140-6736(12)61380-4 ↗
39. In vitro multicompartmental bladder model for assessing blockage of urinary catheters: Effect of hydrogel coating on dynamics of Proteus mirabilis growth10.1016/j.urology.2010.04.039 ↗
40. Strategies for the control of catheter encrustation10.1016/S0924-8579(02)00091-2 ↗
41. Building an antifouling zwitterionic coating on urinary catheters using an enzymatically triggered bottom-up approach10.1021/am501961b ↗
42. Polyethylene glycol-coated biocompatible surfaces10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D ↗
43. Ultrasound coating of polydimethylsiloxanes with antimicrobial enzymes10.1039/C5TB00671F ↗
44. Bacterial adhesion on PEG modified polyurethane surfaces10.1016/S0142-9612(97)00245-7 ↗
45. Antifouling and Antibacterial Multifunctional Polyzwitterion/Enzyme Coating on Silicone Catheter Material Prepared by Electrostatic Layer-by-Layer Assembly10.1021/acs.langmuir.5b04303 ↗
46. Brush-like polycarbonates containing dopamine, cations, and PEG providing a broad-spectrum, antibacterial, and antifouling surface via one-step coating10.1002/adma.201402059 ↗
47. Recent progress in bio-inspired biofilm-resistant polymeric surfaces10.1080/1040841X.2018.1489369 ↗
48. Micro- and Nanotopography Sensitive Bacterial Attachment Mechanisms: A Review10.3389/fmicb.2019.00191 ↗
49. Effect of micro- and nanoscale topography on the adhesion of bacterial cells to solid surfaces10.1128/AEM.03436-12 ↗
50. Micropatterned surfaces for reducing the risk of catheter-associated urinary tract infection: An in vitro study on the effect of sharklet micropatterned surfaces to inhibit bacterial colonization and migration of uropathogenic Escherichia coli10.1089/end.2010.0611 ↗
51. Development of carboxymethyl cellulose-based hydrogel and nanosilver composite as antimicrobial agents for UTI pathogens10.1016/j.carbpol.2015.11.004 ↗
52. Chymotrypsin—Molecular and Catalytic Properties10.1016/S0009-9120(86)80002-9 ↗
53. Non-eluting, surface-bound enzymes disrupt surface attachment of bacteria by continuous biofilm polysaccharide degradation10.1016/j.biomaterials.2018.03.016 ↗
54. Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms10.1126/sciadv.1501632 ↗
55. Catto, C., Secundo, F., James, G., Villa, F., and Cappitelli, F. (2018). alpha-Chymotrypsin Immobilized on a Low-Density Polyethylene Surface Successfully Weakens Escherichia coli Biofilm Formation. Int. J. Mol. Sci., 19.10.3390/ijms19124003 ↗
56. Enzyme multilayer coatings inhibit Pseudomonas aeruginosa biofilm formation on urinary catheters10.1007/s00253-015-6378-7 ↗
57. Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity10.1073/pnas.1702798114 ↗
58. Cellobiose dehydrogenase functionalized urinary catheter as novel antibiofilm system10.1002/jbm.b.33491 ↗
59. Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications10.3390/pathogens3040791 ↗
60. Comparison of urethral reaction to full silicone, hydrogen-coated and siliconised latex catheters10.1111/j.1464-410X.1990.tb07203.x ↗
61. A controlled trial of a new material for coating urinary catheters
62. Force measurements between bacteria and poly(ethylene glycol)-coated surfaces10.1021/la000818y ↗
63. Evaluation of urinary catheters coated with sustained-release varnish of chlorhexidine in mitigating biofilm formation on urinary catheters in dogs10.1111/j.1939-1676.2012.01027.x ↗
64. EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice
65. Fibrinogen Release and Deposition on Urinary Catheters Placed during Urological Procedures10.1016/j.juro.2016.01.100 ↗
66. Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections10.1128/IAI.00856-12 ↗
67. Limoli, D.H., Jones, C.J., and Wozniak, D.J. (2015). Bacterial Extracellular Polysaccharides in Biofilm Formation and Function. Microbiol. Spectr., 3.10.1128/microbiolspec.MB-0011-2014 ↗
68. Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model10.1128/AAC.03786-14 ↗
69. Prevention of encrustation and blockage of urinary catheters by Proteus mirabilis via pH-triggered release of bacteriophage10.1039/C7TB01302G ↗
70. Antibiotic hydrogel coated Foley catheters for prevention of urinary tract infection in a rabbit model10.1097/00005392-199909010-00084 ↗
71. Enhanced Antibacterial and Antiadhesive Activities of Silver-PTFE Nanocomposite Coating for Urinary Catheters10.1021/acsbiomaterials.9b00071 ↗
72. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: A multicenter study10.1016/S0090-4295(99)00318-0 ↗
73. A prospective interventional study to examine the effect of a silver alloy and hydrogel-coated catheter on the incidence of catheter-associated urinary tract infection
74. Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence10.1016/j.juro.2010.07.036 ↗
75. Bioinspired phosphorylcholine containing polymer films with silver nanoparticles combining antifouling and antibacterial properties10.1039/c2bm00155a ↗
76. A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection10.1038/srep23238 ↗
77. Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection10.1128/AAC.43.12.2990 ↗
78. A randomized crossover study of silver-coated urinary catheters in hospitalized patients10.1001/archinte.160.21.3294 ↗
79. Prevention of biofilm formation on urinary catheters: Comparison of the sparfloxacin-treated long-term antimicrobial catheters with silver-coated ones10.1002/jbm.b.32755 ↗
80. Multicenter cohort study to assess the impact of a silver-alloy and hydrogel-coated urinary catheter on symptomatic catheter-associated urinary tract infections10.1097/WON.0000000000000056 ↗
81. Safety and efficacy of a novel silver-impregnated urinary catheter system for preventing catheter-associated bacteriuria: A pilot randomized clinical trial10.1016/j.ajic.2014.11.021 ↗
82. Foley catheters functionalised with a synergistic combination of antibiotics and silver nanoparticles resist biofilm formation10.1049/iet-nbt.2016.0148 ↗
83. Mandakhalikar, K.D., Wang, R., Rahmat, J.N., Chiong, E., Neoh, K.G., and Tambyah, P.A. (2018). Restriction of in vivo infection by antifouling coating on urinary catheter with controllable and sustained silver release: A proof of concept study. BMC Infect. Dis., 18.10.1186/s12879-018-3296-1 ↗
84. Effects of the use of silver-coated urinary catheters on the incidence of catheter-associated bacteriuria and urinary tract infection in dogs10.2460/javma.253.10.1289 ↗
85. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles10.1093/jac/dkn034 ↗
86. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections10.1053/jhin.1999.0715 ↗
87. Antimicrobial functionalization of silicone surfaces with engineered short peptides having broad spectrum antimicrobial and salt-resistant properties10.1016/j.actbio.2013.09.009 ↗
88. Nanoparticles: Emerging carriers for drug delivery10.1016/j.jsps.2011.04.001 ↗
89. Burdusel, A.C., Gherasim, O., Grumezescu, A.M., Mogoantă, L., Ficai, A., and Andronescu, E. (2018). Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview. Nanomaterials, 8.10.3390/nano8090681 ↗
90. Kedziora, A., Speruda, M., Krzyżewska, E., Rybka, J., Łukowiak, A., and Bugla-Płoskońska, G. (2018). Similarities and Differences between Silver Ions and Silver in Nanoforms as Antibacterial Agents. Int. J. Mol. Sci., 19.10.3390/ijms19020444 ↗
91. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters10.1016/j.ijantimicag.2004.02.013 ↗
92. One step green synthesis of phytochemicals mediated gold nanoparticles from Aegle marmales for the prevention of urinary catheter infection
93. Antimicrobial activity of the metals and metal oxide nanoparticles10.1016/j.msec.2014.08.031 ↗
94. Putting copper into action: Copper-impregnated products with potent biocidal activities10.1096/fj.04-2029fje ↗
95. Comparative study of antibiofilm activity of copper oxide and iron oxide nanoparticles against multidrug resistant biofilm forming uropathogens10.1007/s12088-014-0462-z ↗
96. Catheters coated with Zn-doped CuO nanoparticles delay the onset of catheter-associated urinary tract infections10.1007/s12274-016-1310-8 ↗
97. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli10.1016/j.biomaterials.2011.11.057 ↗
98. Changes induced in the permeability barrier of the yeast plasma membrane by cupric ion10.1128/jb.170.6.2676-2682.1988 ↗
99. Biocidal textiles can help fight nosocomial infections10.1016/j.mehy.2007.08.025 ↗
100. Quasi-Instantaneous Bacterial Inactivation on Cu-Ag Nanoparticulate 3D Catheters in the Dark and Under Light: Mechanism and Dynamics10.1021/acsami.5b09730 ↗